Skip to main content

View full-text article in PMC

. 2021 Jan 4;45(3):921–932. doi: 10.3892/or.2021.7920

Table II.

Clinicopathologic variables and CDCA5 expression in PCa patients (n=96).

		CDCA5 expression

Variables	Group	n=96	High	Low	P-value^a
Age (years)	<65	46	32	14	0.56
	≥65	50	32	18
Preoperative PSA	≤10	25	12	13	0.02^b
	>10	71	52	19
Clinical stage	T1	30	16	14	0.06
	T2-3	66	48	18
Gleason score	<7	35	20	15	0.13
	≥7	61	44	17
Seminal vesicle invasion	Absence	36	19	17	0.03^b
	Presence	60	45	15
Lymph node metastasis	Absence	40	22	18	0.04^b
	Presence	56	42	14

^a

P-value was analyzed by Chi-square test

^b

P<0.05 indicates statistical significance. CDCA5, cell division cycle-associated 5; PCa, prostate cancer.